CytoCan

CytoCan

Uses a modular platform called abzed to create fusion proteins with multiple functions.

Market cap
-
Enterprise valuation
€5—8m (Dealroom.co estimates Feb 2023.)
Shaanxi China (HQ)
  • Edit
DateInvestorsAmountRound
*

CNY10.0m

Seed
Total Funding€1.3m

Recent News about CytoCan

Edit